197 related articles for article (PubMed ID: 33010232)
1. Augmentation of NK Cell Proliferation and Anti-tumor Immunity by Transgenic Expression of Receptors for EPO or TPO.
Chanswangphuwana C; Allan DSJ; Chakraborty M; Reger RN; Childs RW
Mol Ther; 2021 Jan; 29(1):47-59. PubMed ID: 33010232
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
Goncalves F; Lacout C; Féger F; Cohen-Solal K; Guichard J; Cramer E; Vainchenker W; Duménil D
Leukemia; 1998 Sep; 12(9):1355-66. PubMed ID: 9737683
[TBL] [Abstract][Full Text] [Related]
3. A functional erythropoietin receptor is necessary for the action of thrombopoietin on erythroid cells lacking c-mpl.
Rouleau C; Cui K; Feldman L
Exp Hematol; 2004 Feb; 32(2):140-8. PubMed ID: 15102474
[TBL] [Abstract][Full Text] [Related]
4. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
Drexler HG; Quentmeier H
Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
8. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin.
Porteu F; Rouyez MC; Cocault L; Bénit L; Charon M; Picard F; Gisselbrecht S; Souyri M; Dusanter-Fourt I
Mol Cell Biol; 1996 May; 16(5):2473-82. PubMed ID: 8628315
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro.
Broudy VC; Lin NL; Kaushansky K
Blood; 1995 Apr; 85(7):1719-26. PubMed ID: 7535585
[TBL] [Abstract][Full Text] [Related]
10. Purinergic targeting enhances immunotherapy of CD73
Wang J; Lupo KB; Chambers AM; Matosevic S
J Immunother Cancer; 2018 Dec; 6(1):136. PubMed ID: 30514403
[TBL] [Abstract][Full Text] [Related]
11. c-MPL provides tumor-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signals.
Nishimura CD; Brenner DA; Mukherjee M; Hirsch RA; Ott L; Wu MF; Liu H; Dakhova O; Orange JS; Brenner MK; Lin CY; Arber C
Blood; 2017 Dec; 130(25):2739-2749. PubMed ID: 29079582
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin and erythropoietin activate inside-out signaling of integrin and enhance adhesion to immobilized fibronectin in human growth-factor-dependent hematopoietic cells.
Gotoh A; Ritchie A; Takahira H; Broxmeyer HE
Ann Hematol; 1997; 75(5-6):207-13. PubMed ID: 9433377
[TBL] [Abstract][Full Text] [Related]
13. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.
Madoiwa S; Komatsu N; Mimuro J; Kimura K; Matsuda M; Sakata Y
Blood; 1999 Jul; 94(2):475-82. PubMed ID: 10397715
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor.
Kieran MW; Perkins AC; Orkin SH; Zon LI
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9126-31. PubMed ID: 8799165
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin modulates the proliferation, migration and cytokine profile of decidual cell subsets during early gestation.
Segerer SE; Martignoni F; Bogdan A; Müller N; Kapp M; Dietl J; Rieger L; Kämmerer U
Mol Hum Reprod; 2013 Jun; 19(6):361-8. PubMed ID: 23340480
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
[TBL] [Abstract][Full Text] [Related]
17. Xanthocillins as thrombopoietin mimetic small molecules.
Sakai R; Nakamura T; Nishino T; Yamamoto M; Miyamura A; Miyamoto H; Ishiwata N; Komatsu N; Kamiya H; Tsuruzoe N
Bioorg Med Chem; 2005 Dec; 13(23):6388-93. PubMed ID: 16115772
[TBL] [Abstract][Full Text] [Related]
18. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
Drexler HG; Quentmeier H
Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling.
Wang Q; Sun R; Wu L; Huang J; Wang P; Yuan H; Qiu F; Xu X; Wu D; Yu Y; Liu X; Zhang Q
Int J Biochem Cell Biol; 2013 Dec; 45(12):2852-63. PubMed ID: 24144576
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Mpl mutants using primary megakaryocyte-lineage cells from mpl(-/-) mice: a new system for Mpl structure-function studies.
Gaur M; Murphy GJ; deSauvage FJ; Leavitt AD
Blood; 2001 Mar; 97(6):1653-61. PubMed ID: 11238104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
